HEALTH● LOW5d ago · Oct 8, 2026, 10:05 PM
Zealand, Roche release phase 2 topline data for amylin analogue petrelintide
Seeking Alpha Tech · global
Zealand and Roche have released initial findings from their phase 2 clinical trials for the amylin analogue petrelintide. This marks a significant update in the development of a potential new pharmaceutical treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH13m agoAquestive rises on licensing deal with Eton for antiseizure therapySeeking Alpha TechHEALTH47m agoSanofi evades EU fine for allegedly disparaging CSL’s flu vaccineSeeking Alpha TechHEALTH55m agoRare cancer spread between twins in uteroNew ScientistHEALTH1h agoPope Leo XIV Found to Have Lung Cancer During SurgeryNBC News